HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,345-1,356 of 1,979
Drug study icon
Recruitment unclearEUCTR 2009-011253-40

Paroxetine or Quetiapine in Addition to Mood Stabilizers in Bipolar Depression

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Italy
Bipolarity, DepressionHistorical research record
Countries
Italy
Sponsor
AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
Other study type icon
Not recruitingISRCTN50788919

Attentional style in Bipolarity

This study isn't currently recruiting.

In United Kingdom
BipolarityResearch study
Countries
United Kingdom
Sponsor
University of Oxford (UK) (University)
Drug study icon
CompletedNCT02363738

12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression

Official study title

A Multisite, Fixed Dose, Randomized, Double-Blind, Placebo-Controlled 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for the Treatment of Bipolar I/II Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Palo Alto
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States, Canada
Sponsor
University Health Network, Toronto
Drug study icon
CompletedNCT01986101

A Phase III Study of SM-13496 in people with Bipolar I Depression.

What is this study about?

Researchers compared SM-13496 and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Tokyo
Bipolarity, DepressionMedication studyAges 18–74
Countries
Japan, Lithuania, Malaysia, + 5 others
Sponsor
Sumitomo Pharma Co., Ltd.
Other study type icon
CompletedNCT03774641

A Study of Prophylactic Management of Lamotrigine in Pregnant Women

Official study title

A Pilot Study of Prophylactic Management of Lamotrigine for Bipolar Disorder in Pregnant Women

This study has finished and is no longer accepting participants.

In Baltimore
Depression, BipolarityObservational studyAges 18+
Countries
United States
Sponsor
Johns Hopkins University
Drug study icon
CompletedNCT00282464

Geodon for depression

Official study title

A Six-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible Doses of Oral Ziprasidone in Outpatients With Bipolar I Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
Bipolarity, DepressionMedication studyAges 18+
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Drug study icon
CompletedNCT00141271

Geodon for depression

Official study title

A Six-Week, Randomized, Double-Blind, Multicenter, Fixed-Flexible Dose, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral Ziprasidone in Outpatients With Bipolar I Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Bipolarity, DepressionMedication studyAges 18+
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Drug study icon
CompletedNCT00167479

Risperidone Monotherapy in Bipolar Anxiety

Official study title

A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Current at Least Moderately Severe Anxiety and Lifetime Panic Disorder or Generalized Anxiety Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Tampa
Bipolarity, AnxietyMedication studyAges 18+
Countries
United States
Sponsor
University of South Florida
Drug study icon
CompletedNCT07549581

SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

Official study title

A Phase 1b, Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Oral Doses of SEP-380135 in Adults With Schizophrenia or With a Major Depressive Episode Associated With Bipolar I or II Disorder or Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Los Alamitos
Depression, Schizophrenia, ...Medication studyAges 18–55
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.